• Earlier this week, Braze reaffirmed its fiscal first quarter and full-year 2027 guidance and reported strong fiscal 2026 results with 24% revenue growth, significant customer expansion, new agentic AI capabilities, and a US$100,000,000 share repurchase authorization.
• Alongside these operational updates, Braze highlighted how its new AI tools and research aim to reshape customer engagement, while investors will soon vote on executive pay, governance changes, and officer exculpation at the June 30, 2026 virtual annual meeting.
• Next, we’ll examine how reaffirmed guidance and the rollout of new agentic AI capabilities may influence Braze’s existing investment narrative.

Invest in the nuclear renaissance through our list of 88 elite nuclear energy infrastructure plays powering the global AI revolution.

Braze Investment Narrative Recap

To own Braze, you need to believe its customer engagement platform and AI roadmap can eventually translate growing revenue into a path toward sustainable profitability. The reaffirmed fiscal 2027 guidance and strong fiscal 2026 results support that broad thesis, but the biggest near term catalyst remains execution on AI driven products like OfferFit and Project Catalyst, while the key risk is still elevated costs and integration complexity. This week’s announcements do not materially change those short term drivers.

The most relevant update for that thesis is Braze’s launch of new agentic AI capabilities under BrazeAI. These tools are positioned to deepen personalization and potentially increase deal sizes, directly tying into catalysts around legacy vendor replacement and vendor consolidation. How effectively customers adopt these AI features, and whether they offset OfferFit related margin pressure, could be central to whether Braze delivers on the growth and efficiency expectations embedded in current guidance.

Yet beneath the AI story and reaffirmed guidance, investors should be aware of how concentrated enterprise customers and elevated costs could still...

Braze's narrative projects $1.2 billion revenue and $139.0 million earnings by 2029. This requires 18.0% yearly revenue growth and a $270.3 million earnings increase from -$131.3 million today.

Uncover how Braze's forecasts yield a $34.95 fair value, a 61% upside to its current price.

Exploring Other Perspectives

Some of the lowest analysts were already cautious, assuming roughly 17.8 percent annual revenue growth and continued losses, and they focus more on risks like heavy reliance on a concentrated enterprise customer base and rising costs that could strain margins; you might see this week’s AI and guidance news as easing those worries or reinforcing them, which is why it helps to compare several viewpoints before deciding where you stand.

Explore 6 other fair value estimates on Braze - why the stock might be a potential multi-bagger!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Braze research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Braze research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Braze's overall financial health at a glance.

Interested In Other Possibilities?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• AI is about to change healthcare. These 29 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Rare earth metals are the new gold rush. Find out which 28 stocks are leading the charge.
• Find 54 companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.